{"id":"W2316887260","doi":"10.1097/01.mib.0000480181.61935.67","title":"P-066 YI Randomized Clinical Trial for Clinical Response Evaluation in Crohnʼs Disease","year":2016,"lang":"en","type":"article","venue":"Inflammatory Bowel Diseases","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Medicine; Infliximab; Erythrocyte sedimentation rate; Internal medicine; Crohn's disease; Adalimumab; Inflammatory bowel disease; Clinical trial; Quality of life (healthcare); Randomized controlled trial; Prospective cohort study; Disease; Repeated measures design; Gastroenterology; Physical therapy","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002263175,0.0007756966,0.003145481,0.0007025951,0.0004048271,0.0006903661,0.0005967626,0.001904922,0.0207147],"category_scores_gemma":[0.002294185,0.0003138536,0.001152652,0.0005668438,0.0008643413,0.0008447584,0.0005194261,0.002684636,0.001792383],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004795323,"about_ca_system_score_gemma":0.001154462,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004489135,"about_ca_topic_score_gemma":0.0006665785,"domain_scores_codex":[0.9988319,0.0007932414,0.00006519599,0.0001124067,0.00008881345,0.0001083358],"domain_scores_gemma":[0.9991436,0.0003637392,0.000161598,0.00005910872,0.00006049532,0.0002114366],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9693442,0.002352879,0.0007743947,0.001323109,0.0005230131,0.00004265392,0.00002352116,0.0001973261,0.0008062882,0.0003377271,0.001463377,0.0228114],"study_design_scores_gemma":[0.9636961,0.0317526,0.002204798,0.0000944341,0.0001461315,0.00002883892,0.00001569707,0.0003651718,0.0000951605,0.0001839106,0.001409491,0.000007653317],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9339446,0.02419616,0.001692873,0.004085057,0.002458254,0.01321488,0.00346996,0.0003890233,0.01654917],"genre_scores_gemma":[0.9501579,0.005898137,0.004425269,0.003525744,0.0009733049,0.01906416,0.0033469,0.00004779069,0.01256065],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0207147,"threshold_uncertainty_score":0.06929755,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04638083229202412,"score_gpt":0.3817124089675608,"score_spread":0.3353315766755367,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}